Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.
Valentina PetaChantal TseHugo PerazzoMona MunteanuYen NgoAn NgoNittia RamanujamLea VerglasMaxime MalletVlad RatziuDominique ThabutMarika RudlerVincent ThibaultIna Schuppe-KoistinenDominique Bonnefont-RousselotBernard HainqueFrançoise Imbert-BismutMichael MerzGerd Kullak-UblickRaul AndradeFlorian van BoemmelEckart SchottThierry Poynardnull nullnull nullPublished in: PloS one (2017)
We identified that apolipoprotein-A1 and haptoglobin had significant predictive values for the prediction of recovery at 12 weeks in DILI, enabling the construction of a new prognostic panel, the DILI-ActiTest, which needs to be independently validated.